Lars Blønd | Orthopedic Surgery | Best Researcher Award

Dr. Lars Blønd | Orthopedic Surgery | Best Researcher Award

Senior Surgeon, The Zealand University of Koege and Aleris-Hamlet Hospitals, Denmark

Dr. Lars Blønd is a distinguished orthopedic surgeon, born in 1961 in Denmark, with specialized expertise in knee and shoulder arthroscopy. He earned his medical degree from the University of Copenhagen in 1991 and became a specialist in orthopedic surgery in 2001. Dr. Blønd is renowned for developing the innovative “Arthroscopic Deepening Trochleoplasty” for patellofemoral surgeries. He is currently practicing at The Zealand University Hospital of Koege and Aleris Hospitals while also contributing to the Danish Patient Safety Authority and Arthrex as a consultant. His career has spanned various roles, including chief surgeon at multiple university hospitals and sports physician for the Danish Superliga soccer team, HB Koege FC. Dr. Blønd’s work has gained international recognition in the field of orthopedic surgery, and he continues to be actively involved in research, contributing to the advancement of orthopedic treatments worldwide. 🏥👨‍⚕️💼

Profile

Education

Dr. Lars Blønd’s education began with his graduation from Gymnasium in 1981, followed by military service in the Danish Navy in 1982. He then pursued his medical studies at the University of Copenhagen (Cph), where he matriculated in 1984 and graduated in 1991. After completing his medical degree, Dr. Blønd specialized in orthopedic surgery, obtaining his certification in June 2001. He also earned a Certificate in Sports Medicine in 2003, further enhancing his expertise in treating athletes and individuals with sports-related injuries. Throughout his career, Dr. Blønd participated in postgraduate training across eight hospitals from 1991 to 2002, which allowed him to develop a comprehensive understanding of orthopedic practices. His diverse educational background and commitment to continuous learning have enabled him to push the boundaries of orthopedic surgery and contribute significantly to the field of sports medicine. 🎓📚🏅

Experience

Dr. Lars Blønd has over three decades of experience in orthopedic surgery, focusing primarily on knee and shoulder arthroscopy. Since 2013, he has worked as a senior surgeon at both The Zealand University Hospital of Koege and Aleris Hospitals, where he continues to provide expert care to patients. In addition to his clinical work, Dr. Blønd holds positions as a consultant for the Danish Patient Safety Authority and as an instructor for Arthrex. Previously, Dr. Blønd served as Chief Surgeon at GHP (2008-2013), Herlev University Hospital (2006-2008), and Gentofte University Hospital (2004-2006). He has also worked part-time as a consultant at Parkens Private Hospital and Nygart Private Hospital and served as a team physician for the Superliga soccer team, HB Koege FC. His extensive clinical experience has shaped his reputation as a leading expert in patellofemoral surgeries and sports medicine. 👨‍⚕️🏥⚽

Research Focus

Dr. Lars Blønd’s research is focused on advancing orthopedic treatments, particularly in the realm of knee and shoulder surgeries. His primary area of expertise lies in patellofemoral disorders, specifically patellar instability, pain syndromes, and dislocations. Dr. Blønd is the inventor of the “Arthroscopic Deepening Trochleoplasty,” a groundbreaking surgical technique designed to address patellofemoral problems. His research also extends to the use of arthroscopy for treating osteoarthritis and injuries related to sports. He has published multiple influential studies on the effectiveness of various treatments for patellar dislocations, patellofemoral pain syndrome, and the use of autologous adipose tissue in osteoarthritis treatment. Dr. Blønd is also dedicated to exploring innovative surgical approaches and the biomechanics of knee and shoulder joint function. His work is widely cited and has contributed to improving patient outcomes in orthopedic surgeries globally. 📊🔬🦵

Publication Top Notes

  1. Patellofemoral pain syndrome in athletes: a 5.7-year retrospective follow-up study of 250 athletes 📚🦵
  2. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty 🩸💉
  3. High incidence of acute and recurrent patellar dislocations: a retrospective nationwide epidemiological study 🦵📈
  4. Combined arthroscopic deepening trochleoplasty and reconstruction of the medial patellofemoral ligament 🏥🔬
  5. Quality assessment of radiological measurements of trochlear dysplasia; a literature review 📐📊
  6. The arthroscopic deepening trochleoplasty 🦵🔧
  7. Treatment of osteoarthritis with autologous and microfragmented adipose tissue 🦵💉
  8. Exsanguination of the upper limb in healthy young volunteers 🦵🤕
  9. Arthroscopic treatment for snapping scapula: a prospective case series 🦵⚙️
  10. Translation, adaptation and measurement properties of an electronic version of the Danish WOSI 🖥️📊

 

 

Mohammad Kamalabadi Farahani | Sustainability in Construction | Best Researcher Award

Mr. Mohammad Kamalabadi Farahani | Sustainability in Construction | Best Researcher Award

Master’s degree graduate, Iran university of science and technology, Iran

Mohammad Kamalabadi Farahani is a forward-thinking construction engineer with expertise in sustainable building practices. With a Master’s degree in Construction Engineering and Management from Iran University of Science and Technology (IUST), Mohammad specializes in eco-efficient building materials, waste management, and energy-efficient buildings. His research interests are rooted in sustainability, particularly in developing innovative construction materials like composite bricks. Mohammad is currently working as a Project Manager and Construction Engineer at Pars Construction Group. His dedication to both practical and theoretical aspects of construction engineering makes him a promising figure in the field. 🌍🏗️

Profile:

Google Scholar

Education:

Mohammad holds an MSc in Construction Engineering and Management from Iran University of Science and Technology (2021-2023) with an impressive GPA of 3.77/4. He completed his BSc in Civil Engineering at Islamic Azad University (2015-2019), with a strong academic record. At IUST, his research focused on sustainable construction materials, which provided a solid foundation for his future work in the eco-efficient construction industry. His academic journey reflects a deep commitment to excellence, combining theoretical knowledge with practical skills. 📚🎓

Experience:

Mohammad Kamalabadi Farahani is currently serving as a Project Manager and Construction Engineer at Pars Construction Group since 2019. His role involves managing projects, coordinating construction activities, and ensuring sustainable practices are followed throughout the construction process. With hands-on experience in project management and construction engineering, Mohammad applies his research-driven insights into real-world projects. His ability to bridge the gap between research and industry makes him a valuable asset in the field of sustainable construction. 🛠️🏢

Awards and Honors:

Mohammad has been recognized for his outstanding academic performance, particularly for his master’s thesis, which he completed with an excellent grade of 19.5/20 at Iran University of Science and Technology. This achievement highlights his dedication to research and excellence. His hard work and contributions to sustainable construction practices are also evident in his published research, which has gained attention within the academic community. His recognition is a testament to his potential in advancing sustainable construction. 🏅👏

Research Focus:

Mohammad’s research focus centers on sustainable construction, eco-efficient building materials, and energy-efficient building design. He specializes in the development of composite bricks made from natural zeolite and recycled materials like sugarcane bagasse ash and mushroom compost. His research aims to reduce the environmental impact of construction materials while improving energy performance in buildings. Mohammad’s work supports the global shift towards more sustainable and environmentally responsible construction practices. 🌱🏠

Publication Top notes:

  1. Natural zeolite composite bricks containing sugarcane bagasse ash: An innovative sustainable construction material – Journal of Material Cycles and Waste Management (Dec 2024)
  2. Building Energy Simulation of Eco-efficient Composite Bricks Using a Novel Method to Convert Ceramic Bricks into Building Blocks: Case Study in Iran – Infrastructures (Feb 2025)

 

 

Dharambir Sanghera | Biomarker discovery | Best Researcher Award

Dr. Dharambir Sanghera | Biomarker discovery | Best Researcher Award

Professor, Uni of Oklahoma Health Sciences Center, United States

Dr. Dharambir K. Sanghera is a distinguished Professor of Pediatrics/Genetics and the Presidential Professor and Dr. Geoffrey Altshuler Endowed Research Chair in Genetics at the University of Oklahoma Health Sciences Center. His academic journey spans across several prestigious institutions globally, including the University of Pittsburgh and Guru Nanak Dev University, Amritsar, India. He is an internationally recognized leader in the field of genetic epidemiology and statistical genetics, with significant contributions to the understanding of genetic influences on diabetes, cardiovascular disease, and other complex traits. He has led several large international research consortia, including the South Asian Diabetes Genetics Consortium and the Global Telomere Genetics Consortium. His work has been instrumental in identifying novel genetic loci associated with various diseases, and his research continues to shape the future of personalized medicine.

Profile

Education 

Dr. Sanghera holds an impressive educational background, starting with his Bachelor’s and Master’s degrees in Medical and Biochemical Genetics from Guru Nanak Dev University and Punjab Agricultural University, India. He earned his Ph.D. in Human Genetics and Genetic Toxicology from Guru Nanak Dev University. Furthering his expertise, Dr. Sanghera completed fellowships in Genetic Epidemiology/Statistical Genetics and Molecular Mutagenesis at the Graduate School of Public Health, University of Pittsburgh, USA. These formative experiences equipped him with a robust understanding of human genetics, statistical modeling, and molecular toxicology, laying the foundation for his pioneering research in genetic epidemiology. His commitment to advancing genetic research has helped him develop a multidisciplinary approach, integrating genetics, public health, and epidemiology to address complex health issues, particularly in diverse populations.

Experience

Dr. Dharambir K. Sanghera has had an extensive career, with over three decades of experience in academia and research. Since 2007, he has been a Professor in the Department of Pediatrics at the University of Oklahoma Health Sciences Center, where he is also an adjunct professor in the Departments of Pharmaceutical Sciences and Physiology. Over the years, he has held various roles, including Associate Professor and Research Assistant Professor, at the University of Pittsburgh, as well as consultant and honorary positions at institutions in India. His academic involvement spans teaching, mentoring, and collaborating with researchers across the globe. Dr. Sanghera has been a leader of numerous international research consortia, such as the South Asian Diabetes Genetics Consortium and the Global Telomere Genetics Consortium, focusing on diabetes, cardiovascular diseases, and genomic health disparities. His contributions to academic and research leadership continue to inspire innovation in the field of genetics.

Awards and Honors

Dr. Sanghera has received numerous prestigious honors throughout his career, recognizing his outstanding contributions to genetics and biomedical research. In 2023, he was appointed Presidential Professor at the University of Oklahoma Health Sciences Center, acknowledging his excellence in research and leadership. He was also honored with the Dr. Geoffrey Altshuler Endowed Research Chair in Genetics in 2019. Dr. Sanghera has been a recipient of the Regents Award for Superior Research and Creative Activities, the International Fellow of the American Heart Association (FAHA), and several Who’s Who recognitions, including in America, Women, and the World. Additionally, he has been awarded numerous mentoring and research accolades, including the Mentor Award for Best Research Topic at Pediatrics Research Day. His leadership in multiple consortia and committees, such as the NIH/NIMHD/SEP Study Section, demonstrates his global influence in advancing genetic research.

Research Focus

Dr. Dharambir K. Sanghera’s research focuses on the intersection of human genetics, epidemiology, and precision medicine. He has made significant strides in understanding the genetic underpinnings of complex diseases such as type 2 diabetes, cardiovascular diseases, obesity, and neurodegenerative disorders. A key part of his work is identifying genetic loci that contribute to these conditions, especially within diverse populations like South Asians. Dr. Sanghera has pioneered the use of multiethnic genome-wide association studies (GWAS) to improve risk prediction and tailor interventions. His work with international consortia, including the South Asian Diabetes Genetics Consortium and Global Telomere Genetics Consortium, has led to important discoveries in genetic susceptibility. Moreover, Dr. Sanghera’s research extends to exploring the role of genetic variation in telomere biology, vitamin D metabolism, and metabolic diseases. His research continues to shape the future of personalized healthcare, emphasizing the importance of genetics in disease prevention and treatment.

Publication Top Notes

  1. Genetic studies of body mass index yield new insights for obesity biology. 🌍🧬
  2. Discovery and refinement of loci associated with lipid levels. 🔬💡
  3. A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease. 💔🧬
  4. New genetic loci link adipose and insulin biology to body fat distribution. 🧑‍⚕️⚖️
  5. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke. 🧠🔎
  6. Common variants associated with plasma triglycerides and risk for coronary artery disease. 💉💪
  7. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. 🧬🍎
  8. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. 🧑‍⚕️🍚
  9. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. 💔🧬
  10. A saturated map of common genetic variants associated with human height. 📏🧬

 

 

Evgeny Sidorov | Stroke | Best Researcher Award

Dr. Evgeny Sidorov | Stroke | Best Researcher Award

Professor, Uni of Oklahoma Health Sciences Center, United States

Dr. Evgeny Vadimovich Sidorov is a distinguished Professor of Neurology at the University of Oklahoma College of Medicine, specializing in vascular and inpatient neurology. With expertise in stroke management, he is also the Program Director for the Vascular Neurology Fellowship Program. Dr. Sidorov’s academic journey includes a PhD in Neurosurgery from the Russian Medical Academy and a Master of Health Administration from the University of British Columbia. His clinical interests encompass stroke prevention and post-stroke rehabilitation. He is actively involved in numerous clinical trials and research, with a focus on ischemic stroke, cerebral hemorrhage, and neurological recovery. Dr. Sidorov has received several prestigious awards, including the “Outstanding Teacher Award” from the University of Oklahoma. He remains a prominent figure in advancing stroke treatment and research, both in academia and clinical practice.

Profile

Education

Dr. Evgeny Sidorov holds a medical degree from the Ural State Medical Academy in Russia (1991-1997). He pursued postgraduate education at the Russian Medical Academy of Postgraduate Studies, where he completed a PhD in Neurosurgery (1997-2003). Dr. Sidorov then earned a Master of Science in Health Administration from the University of British Columbia, Canada (2003-2005). He completed his medical training at the University of Oklahoma Health Sciences Center, where he was involved in neurology residency (2007-2010) and served as Administrative Chief Resident in 2009-2010. His fellowship training in Vascular Neurology at Harvard Medical School (2010-2011) shaped his expertise in stroke medicine and neurovascular care. With a solid foundation in both clinical and administrative aspects of healthcare, Dr. Sidorov is committed to advancing neurology education and research, with a particular focus on vascular neurology and stroke recovery.

Experience

Dr. Evgeny Sidorov has a rich academic career with the University of Oklahoma College of Medicine, where he serves as a Professor in the Department of Neurology, focusing on vascular and inpatient neurology. He joined the university in 2011, initially as an Assistant Professor, before advancing to Associate Professor in 2017, and later to Professor in 2023. As the Program Director for the Vascular Neurology Fellowship Program, Dr. Sidorov has mentored numerous fellows in neurology. He has also held administrative roles, including Section Chief of Vascular and Inpatient Neurology since 2021. With a strong background in both clinical care and education, Dr. Sidorov has been integral in the development of stroke care protocols and rehabilitation techniques. His practice spans clinical leadership, mentorship, and research, consistently advancing the field of neurology with a commitment to improving patient care and outcomes for stroke survivors.

Awards and Honors

Dr. Sidorov has received numerous prestigious awards throughout his career. He is a Fellow of the American Heart/Stroke Association (2020-present), acknowledging his significant contributions to stroke medicine. His leadership and commitment to education earned him the College of Medicine Alumni Research Scholar Award in 2020-2021. Dr. Sidorov’s exceptional teaching abilities were recognized with the Outstanding Teacher Award from the Clinical Curriculum Subcommittee in 2019-2020. Additionally, he was named the Most Influential Teacher in the Department of Neurology (2017-2018). His contributions to the field have earned him national recognition, including being selected as a Travel Scholar by the American Neurological Association in 2008 and an International Fellow by the Henry Ford Foundation (2003-2005). These accolades reflect Dr. Sidorov’s dedication to advancing stroke care, educating future neurology leaders, and contributing to the global understanding of vascular neurology.

Research Focus

Dr. Sidorov’s research focus centers on ischemic stroke, intracerebral hemorrhage, stroke rehabilitation, and neurovascular disorders. His clinical trials explore novel stroke treatments, including anticoagulation therapies, statins, and advanced diagnostic tools for stroke prediction and recovery. Dr. Sidorov’s ongoing studies investigate serum biomarkers for large vessel occlusion and the relationship between thyroid hormone changes and stroke severity. Additionally, his work in brain plasticity aims to enhance post-stroke recovery through innovative approaches like high-definition transcranial direct current stimulation (HD-tDCS). He is also involved in collaborative projects that combine neuroimaging techniques to study brain connectivity and reorganization in stroke survivors. Dr. Sidorov’s research aims to improve patient outcomes by developing predictive models, exploring genetic and molecular markers, and advancing personalized treatment strategies. Through his clinical and translational research, Dr. Sidorov continues to lead the way in understanding and treating vascular neurology.

Publication Top Notes

  1. Improving Stroke Outcome Prediction Using Molecular and Machine Learning Approaches in Large Vessel Occlusion 🧠💻
  2. Contribution of Circulating Mfge8 to Human T2DM and Cardiovascular Disease 💉❤️
  3. Alteration in Resting-State Brain Activity in Stroke Survivors Following Repetitive Finger Stimulation 🧠✋
  4. Decrease of Thyroid Function After Ischemic Stroke Is Related to Stroke Severity 🧠💡
  5. High-Definition Transcranial Direct Current Stimulation for Upper Extremity Rehabilitation in Moderate-to-Severe Ischemic Stroke 🧠🔌
  6. Discovery and Validation of Circulating Stroke Metabolites by NMR-Based Analyses Using Patients from the MISS and UK Biobank 🔬🧪
  7. Difference in Acute and Chronic Stage Ischemic Stroke Metabolic Markers with Controls 🔬🧠
  8. Predictors of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease ❤️💔
  9. Cortical Reorganization of Early Somatosensory Processing in Hemiparetic Stroke 🧠🖐
  10. Quantitative Analysis of Stress-Induced Hyperglycemia and Intracranial Blood Volumes for Predicting Mortality After Intracerebral Hemorrhage 💉🧠

 

 

Mohammed Hefni | Mass Spectrometry | Best Researcher Award

Assoc. Prof. Dr. Mohammed Hefni | Mass Spectrometry | Best Researcher Award

Linnaeus University, Sweden

Dr. Mohammed Hefni is a Senior Researcher at Linnaeus University, Sweden, with a passion for sustainable, nutritious food development and health-impact clinical trials. His research spans chromatographic analysis, food science, and health, focusing on the intersection of nutrition and food processing. In addition to his research work, Dr. Hefni teaches nutrition, food chemistry, and analytical chemistry courses, helping shape the future of young scientists. His broad academic background and extensive research across Sweden, Egypt, and other global research centers, such as Uppsala and New Zealand, have allowed him to contribute significantly to advancing knowledge in food science and health outcomes.

Profile

Google scholar

Education 🎓

Dr. Hefni obtained his PhD in Food Science, co-supervised by the Swedish University of Agricultural Sciences and Mansoura University, focusing on folate in Egyptian foods and how food processing and bio-processing impact its levels. Prior to that, he earned an MSc and a BSc in Food Science from Mansoura University, where he conducted research on children’s nutrition. His education in food science, backed by strong international experience, has made him a leader in his field, continually pushing boundaries in nutrition and food research.

Experience 💼

Dr. Hefni has extensive academic experience, transitioning from Assistant Lecturer to Associate Professor at Mansoura University, Egypt, and later joining Linnaeus University as a Senior Researcher in 2016. His career spans teaching, research, and international collaborations. He has worked on cutting-edge food science projects as a postdoctoral researcher in Sweden, New Zealand, and Poland. His expertise in chromatographic techniques, bioactive peptides, and food processing has made him a key figure in both food science education and research. Additionally, his contributions in research and teaching have fostered the development of new methodologies and innovations in nutrition and food chemistry.

Awards and Honors 🏅

Dr. Hefni’s remarkable career has been recognized through numerous awards. These include the University Research Award at Mansoura University (2010, 2012), the University Incentive Award (2015), and several international scholarships. His contributions to food science research have been bolstered by training grants and fellowship awards from renowned institutions in Poland, New Zealand, and the UK. His award-winning research highlights his expertise in areas like bioactive peptides, folate profiling, and sustainable food development. These accolades underscore his ongoing commitment to advancing scientific knowledge in nutrition and food chemistry.

Research Focus 🔬

Dr. Hefni’s research focuses on sustainable food development, particularly nutrition and food chemistry, and their connection to health outcomes. He works extensively with chromatographic analysis and clinical trials to assess the health impacts of foods, especially legumes and plant-based diets. His recent work explores improving folate content in Egyptian foods and investigating bioactive compounds such as peptides. His research is essential for developing food products that contribute to better health and sustainability, emphasizing the potential of food processing and bio-processing methods to enhance nutrition.

Publication Top Notes📚

  • Less meat, more legumes: prospects and challenges in the transition toward sustainable diets in Sweden (2020)
  • High-moisture meat analogues produced from yellow pea and faba bean protein isolates/concentrate (2021)
  • Folate content in foods commonly consumed in Egypt (2010)
  • Folate content in processed legume foods commonly consumed in Egypt (2014)
  • Increasing the folate content in Egyptian baladi bread using germinated wheat flour (2011)
  • Folate content in faba beans (Vicia faba L.)—effects of cultivar, maturity stage, industrial processing, and bioprocessing (2015)
  • The application of pulse flours in the development of plant-based cheese analogues (2021)
  • Characterization of flavonoid compounds in common Swedish berry species (2020)
  • Effect of germination and subsequent oven-drying on folate content in different wheat and rye cultivars (2012)
  • Flours from Swedish pulses: Effects of treatment on functional properties and nutrient content (2019)
  • A HPLC-UV method for the quantification of phenolic acids in cereals (2019)
  • Bread making with sourdough and intact cereal and legume grains–effect on glycaemic index and glycaemic load (2021)
  • Betaine, choline and folate content in different cereal genotypes (2018)
  • A simple HPLC method with fluorescence detection for choline quantification in foods (2015)

 

 

Sumathi Robert Shanmugam | Nursing | Best Researcher Award

Assist. Prof. Dr. Sumathi Robert Shanmugam | Nursing | Best Researcher Award

Assistant Professor, Princess Nourah bint Abdulrahaman University, Saudi Arabia

Dr. Sumathi Robert Shanmugam is an accomplished academician and researcher in the field of nursing. Currently serving as an Assistant Professor at the College of Nursing, Princess Nourah Bint Abdulrahman University in Riyadh, Saudi Arabia, she brings over 29 years of teaching experience. Dr. Shanmugam holds a Ph.D. in Pediatric Nursing, specializing in advancing educational practices and innovative clinical assignments. She is passionate about improving academic standards and student learning through technology-based teaching methods and has contributed significantly to the development of nursing curricula and research methodology. Her work focuses on pediatric care, nursing education, and women’s health, and she is actively involved in mentoring research scholars and guiding students in research methodologies. With multiple publications in reputable journals and awards such as the Distinguished Teacher Award for 2023, Dr. Sumathi is recognized as a leader in nursing education and research.

Profile

Education

Dr. Sumathi Robert Shanmugam earned her Ph.D. in Pediatric Nursing, where she delved into the complexities of child health and nursing care. She holds a robust academic background, having completed advanced studies in nursing sciences, which laid the foundation for her extensive career in academia and research. Over the years, Dr. Sumathi has continuously sought to enhance her professional knowledge by engaging in numerous academic courses and workshops, ensuring that she stays at the forefront of nursing education. Her dedication to the field of nursing is reflected in her active contributions to the development of nursing curricula, particularly in Bachelor of Maternity Nursing programs. Dr. Shanmugam’s academic achievements have earned her recognition in the form of the Distinguished Teacher Award 2023, which serves as a testament to her commitment to shaping future generations of nurses. Her academic credentials and ongoing contributions continue to make her a leading figure in the field of nursing education.

Experience

With over 29 years of experience in nursing education, Dr. Sumathi Robert Shanmugam has carved a distinguished career in both teaching and research. Throughout her career, she has successfully implemented technology-based teaching methods that have transformed traditional classroom settings, bringing innovation into nursing education. Dr. Shanmugam has also contributed to the academic world by developing clinical assignments and simulation training programs, which help students hone their skills in real-world scenarios. Beyond her teaching role, she actively mentors students and researchers, guiding them through research methodology, data analysis, and manuscript writing. Her leadership extends to her role as a Research Mentor for Ph.D. scholars, where she fosters research growth in nursing. Additionally, Dr. Shanmugam has had key editorial roles, contributing to Paediatric Nursing Journals and co-authoring chapters in nursing textbooks. Her work continues to influence nursing education, both in Saudi Arabia and internationally.

Research Focus

Dr. Sumathi Robert Shanmugam’s research interests span a wide range of critical topics within the nursing domain, with a particular emphasis on Pediatric care, Women’s and Child Health, Nursing Education, and the use of Simulation in Nursing. Her focus on nursing education includes developing new curricula and enhancing training programs for better practical application and academic delivery. Additionally, Dr. Shanmugam has explored the psychological aspects of healthcare, particularly through research examining emotional intelligence and well-being among nursing students. Her research on simulation-based training is particularly noteworthy, as it bridges the gap between theory and practice, ensuring that future nurses are well-prepared for the challenges they will face in real-world clinical settings. Dr. Shanmugam is also involved in collaborative research projects, such as studies on psychological health, addiction recovery, and the impact of COVID-19 on mental health in various populations, making her research both diverse and impactful.

Publication Top Notes

  • Levels of depression among wives of alcoholics and non-alcoholics-A comparative study (Indian Journal of Psychiatric Nursing, 2018) 🌍📚
  • Impact of sleep and psychological well-being on the academic and clinical performance of nursing students in Saudi Arabia (Psychology Research and Behavior Management, 2024) 🌙📈
  • Emotional intelligence and self-esteem among Saudi Arabian and Indian nursing students: findings from two countries (BMC Nursing, 2024) 🌟💡
  • Awareness, Perceived Benefits and Barriers of Usage of Open Access Scholarly Publishing among Faculty (Cardiometry, 2023) 🖋️📑
  • Effectiveness of music therapy on pain, anxiety, depression and quality of life among patients with cancer—A systematic review (Int J Nurs Health Care Res, 2023) 🎶💪
  • Psychological effects of COVID-19 lockdown among Aseer residents, Saudi Arabia (JPMA, 2023) 🦠😷
  • Facilitators and Barriers for Advocacy among Nurses-A Cross-Sectional Study (The Malaysian Journal of Nursing, 2024) 🧑‍⚕️🤝
  • WhatsApp Addiction and Educators Role in WhatsApp usage among Students (Psychology and Education, 2021) 📱👨‍🏫
  • Quality of life among wives of juvenile diabetics (Tamilnadu Nurses and Midwives Council, 2018) ❤️📊
  • Psychological problems among children of alcohol dependents with children of juvenile diabetics (The Journal of Nursing Trendz, 2018) 🧒🍷
  • Psychological problems among wives of alcohol dependents with wives of Juvenile diabetics and normal controls (Indian Journal of Advanced Nursing, 2018) 🧠💔
  • Deep Tissue Massage (Journal of Medical Surgical Nursing, 2014) 💆‍♀️📖
  • Collaborative newborn care- Nurses Role (Nightingale Nursing Times, 2010) 👶🤱
  • Newborn care practices (Health Action, 2010) 🍼👶

 

 

Assel Tleukeyeva | Biotechnology | Best Researcher Award

Dr. Assel Tleukeyeva | Biotechnology | Best Researcher Award

Scientific researcher, M.Auezov South Kazakhstan university, Kazakhstan

Assel Tleukeyeva is a researcher at M.Auezov South Kazakhstan State University in Shymkent, Kazakhstan, since 2008. With a passion for environmental science and biotechnology, she has contributed to numerous publications focusing on microalgae, medicinal plant extracts, and the development of sustainable cosmetic products. Her extensive research interests have led to a variety of innovations, including the application of green microalgae in agriculture and cosmetics. Assel is a dedicated academic with a drive to promote sustainable practices in agriculture and environmental sciences.

Profile

Orcid

Education

Assel Tleukeyeva is currently pursuing her Ph.D. at M.Auezov South Kazakhstan State University since 2010. Her academic journey has been deeply intertwined with cutting-edge research in biotechnology, environmental sciences, and sustainable agricultural practices. With a strong academic foundation, Assel has been able to combine her education with practical research aimed at solving environmental challenges and improving the use of natural resources for agricultural and cosmetic applications.

Experience

Assel Tleukeyeva has worked as a researcher at M.Auezov South Kazakhstan State University since 2008. Her research spans various topics, including the use of green microalgae for biofertilizers, developing cosmetic products from local plant materials, and exploring sustainable agricultural practices. She is involved in various international journal publications and actively contributes to advancing the use of bio-based resources for environmental sustainability. Her career showcases a strong commitment to interdisciplinary research and innovation, particularly in the field of agro-biotechnology.

Research Focus

Assel Tleukeyeva’s research focuses on the potential of microalgae, medicinal plants, and salt-containing raw materials from the southern regions of Kazakhstan for various applications in agro-biotechnology, agriculture, and cosmetics. Her studies have explored the properties of green microalgae like Chlorella vulgaris, emphasizing their applications in agriculture as biofertilizers and in sustainable cosmetic product development. She is also keen on the bioremediation of soils contaminated with industrial waste and the possibilities of using plant-based materials for sustainable cosmetic products. Assel is committed to advancing eco-friendly practices and creating solutions that blend scientific innovation with environmental stewardship.

Publication Top Notes

  1. Fungicidal properties of green microalgae chlorella vulgaris 🍃🦠
  2. Investigation into the possibilities of using plant raw materials from the southern region of Kazakhstan to produce cosmetology products 🌿💧
  3. Selection of the composition of the fertilizer and optimal factors for the cultivation of green microalgae on phosphorus—Containing waste in the south of Kazakhstan 🌱💡
  4. Study of the Properties of New Strains of Green Microalgae Cultivated on Residual Phosphorus-Containing Waters 🌱🔬
  5. Study of the Possibility of Biorecultivation of Soils Contaminated with Brown Coal Waste 🌍♻️
  6. Soil Pollution with Heavy Metals in Turkestan Region 🌱⚠️
  7. Possibilities of Using Medicinal Plant Extracts and Salt-Containing Raw Materials from the Aral Region for Cosmetic Purposes 🌱💧
  8. Reaction of Aquatic Plants of Small Rivers of the Turkestan Region of Kazakhstan to Heavy Metal Ions 🌿💦
  9. The Use of Phosphorus-Containing Waste and Algae to Produce Biofertilizer for Tomatoes 🌱🍅
  10. Green Algae as a Way to Utilize Phosphorus Waste 🌱♻️

 

Roosevelt Desronvilles | Regenerative Medicine | Best Researcher Award

Mr. Roosevelt Desronvilles | Regenerative Medicine | Best Researcher Award

Orthobiologics Research Initiative Inc., United States

Roosevelt Desronvilles is a dynamic and driven clinical research coordinator with a strong foundation in regenerative medicine. With a background in molecular and cellular biology, he has demonstrated leadership and innovation in clinical trials and research focused on orthobiologics and tissue regeneration. He is currently involved in groundbreaking research on micro-fragmented adipose tissue, platelet-rich plasma, and stem cell therapies for musculoskeletal and neurological conditions. Roosevelt’s extensive experience spans clinical research, data collection, grant writing, and manuscript submission. He has published in prominent journals and actively participates in conferences, advocating for novel regenerative treatments. His academic rigor, hands-on experience, and dedication to advancing medical science make him a distinguished contributor to his field.

Profile

Orcid

Education

Roosevelt Desronvilles earned his Bachelor of Science in Molecular and Cellular Biology from Johns Hopkins University in May 2021. His education provided a strong foundation in molecular biology, cell physiology, and experimental research techniques. At Johns Hopkins, Roosevelt engaged in cutting-edge laboratory research, developing the technical expertise and problem-solving skills necessary for success in clinical and translational science. His coursework and hands-on experiences at the university’s prestigious laboratories prepared him to approach complex biological questions with precision and a multidisciplinary perspective. Roosevelt’s academic achievements have enabled him to transition smoothly into professional roles within clinical research, where he continues to apply the knowledge and methodologies learned at Johns Hopkins to real-world challenges in regenerative medicine and clinical trials.

Experience

Roosevelt Desronvilles has extensive hands-on experience in clinical research and medical practices. He currently works as a Clinical Research Coordinator at Orthobiologics Research Initiative, where he co-designed and managed clinical trials, including a study on the effectiveness of micro-fragmented adipose tissue for rotator cuff tears. Roosevelt’s role includes grant writing, manuscript submission, and contributing to pivotal research on orthobiologics like bone marrow aspirate and platelet-rich plasma. He also works as a Medical Scribe/Research Assistant at Regenerative Orthopedics and Sports Medicine, performing diagnostic tasks and assisting in the preparation and administration of various biologic treatments. In the past, he was a Clinical Allergy Specialist at United Allergy Services, administering allergy tests and providing immunotherapy treatments. Roosevelt has presented his research at medical conferences and has been involved in multiple publications, underscoring his commitment to advancing the field.

Research Focus

Roosevelt Desronvilles’ research focuses on regenerative medicine, particularly the use of orthobiologics for musculoskeletal and neurological conditions. He is passionate about exploring the therapeutic potential of micro-fragmented adipose tissue, bone marrow aspirate, platelet-rich plasma, and stellate ganglion blocks. His research aims to improve the outcomes of clinical treatments for conditions such as rotator cuff tears, hip osteoarthritis, and post-traumatic stress disorder (PTSD). Roosevelt’s work in clinical trials and data collection is driven by the desire to improve patient care and explore alternative therapies for conditions that may benefit from regenerative approaches. His published studies and ongoing research highlight the effectiveness and long-term durability of these therapies, contributing valuable insights to the field of regenerative medicine.

Publication Top Notes

  1. Three-Month Durability of Bilateral Two-Level Stellate Ganglion Blocks in Patients with Generalized Anxiety Disorder: A Retrospective AnalysisBrain Sciences (2025)
  2. Long-Term Durability of Bilateral Two-Level Stellate Ganglion Blocks in Posttraumatic Stress Disorder: A Six-Month Retrospective AnalysisClinical and Translational Neuroscience (2025)
  3. Regeneration of Full-Thickness Common Extensor Tendon Tear After Percutaneous Microfragmented Adipose GraftRegenerative Medicine (2024)
  4. Treating External Anal Sphincter Injury with Platelet-Rich Plasma to Resolve Postpartum Fecal Incontinence Caused by Birthing Trauma: A Case ReportJournal of Case Reports and Images in Obstetrics and Gynecology (2025)

 

 

Luigi Sebastiano Battaglia | brain disease targeting | Best Researcher Award

Prof. Luigi Sebastiano Battaglia | brain disease targeting | Best Researcher Award

Associate Professor, University of Turin, Italy

Luigi Sebastiano Battaglia is an Associate Professor in Pharmaceutical Technology at the University of Turin, where he has made significant contributions to the field of pharmaceutical science. His work focuses on innovative drug delivery systems, particularly using solid lipid nanoparticles (SLNs) and nanoemulsions. With a PhD in Drug Science from the University of Turin, Luigi has built a successful career in both academia and industry. He has been involved in numerous research projects aimed at advancing the treatment of brain diseases, including gliomas and neurodegenerative conditions, through nanotechnology. Luigi has published extensively in top-tier journals and holds multiple patents for his groundbreaking work. He collaborates with several prestigious institutions and is a recognized expert in drug targeting and delivery systems.

Profile

Education 

Luigi Sebastiano Battaglia completed his degree in Pharmacy at the University of Turin in 2002. He continued his academic journey with a PhD in Drug Science from the same institution in 2009. Over the years, he has held several academic roles at the University of Turin, including Research Associate, Assistant Professor, and Tenure-track Assistant Professor, before becoming an Associate Professor in Pharmaceutical Technology in 2020. His academic training has laid the foundation for his pioneering research in pharmaceutical technology, drug delivery, and nanomedicine. Battaglia has actively engaged in national and international collaborations, further enhancing his knowledge and expertise in the field.

Experience

Luigi Battaglia has more than two decades of experience in pharmaceutical technology and nanomedicine. He started his career as a Research Associate in the Department of Drug Science and Technology at the University of Turin, where he worked from 2006 to 2012. In 2012, he became an Assistant Professor at the Faculty of Pharmacy, later transitioning to a Tenure-track position at the Department of Drug Science and Technology. Since 2020, Luigi has been serving as an Associate Professor. Throughout his career, he has led several significant research projects, securing funding from various national and European sources. He has published over 70 articles in top scientific journals and is the author of numerous book chapters and patents. Luigi’s consultancy work with companies such as R BioTransfer further demonstrates his expertise in applying scientific knowledge to real-world challenges, particularly in cancer treatment and brain disease therapies.

Research Focus

Luigi Sebastiano Battaglia’s research focuses on the development of innovative drug delivery systems, with a particular emphasis on solid lipid nanoparticles (SLNs) and nanoemulsions. His work aims to address major challenges in the treatment of brain diseases, including gliomas, neurodegenerative disorders, and cerebrovascular conditions. Luigi has pioneered the preparation of ultrasmall SLNs and the functionalization of nanoemulsions with cell membrane fragments, allowing for more targeted and efficient drug delivery. His research also explores surface modifications of nanocarriers to enhance the transport of biologically active compounds across biological barriers such as the blood-brain barrier. A significant part of his research is dedicated to overcoming obstacles in drug targeting, particularly for cancer therapies. Through his innovative approach, Luigi aims to improve the efficacy and safety of drug treatments for various neurological conditions and disorders.

Publication Top Notes

  • Green Solid Lipid Nanoparticles by Coacervation of Fatty Acids: An Innovative Cosmetic Ingredient for the Delivery of Anti-Age Compounds Through the Skin 🌱💊
  • Ultrasmall Solid Lipid Nanoparticles as a Potential Innovative Delivery System for a Drug Combination Against Glioma 🧠💉
  • Concanavalin A Grafted Nanoemulsions for Nasal Delivery: Preliminary Studies with Fluorescently Labelled Formulations 👃💡
  • Green Solid Lipid Nanoparticles by Fatty Acid Coacervation: An Innovative Nasal Delivery Tool for Drugs Targeting Cerebrovascular and Neurological Diseases 🌿🧠
  • Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas 🧬💉
  • Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders 🔬🧠
  • Alendronate-Grafted Nanoemulsions for Bone-Targeted Vincristine Delivery: Preliminary Studies on Cell and Animal Models 🦴💊

 

 

Shaghayegh Baradaran Ghavami | Molecular Biology | Best Researcher Award

Dr. Shaghayegh Baradaran Ghavami | Molecular Biology | Best Researcher Award

IBD research, Research institutes gastroenterology and liver, Iran 

Shaghayegh Baradaran Ghavami is a dedicated researcher with over 10 years of expertise in immunology, microbiology, and molecular biology. Specializing in autoimmune diseases like Inflammatory Bowel Disease (IBD), her work focuses on innovative therapies such as probiotics, nanocomposites, and viral infection impacts on immune responses in autoimmune patients. She is highly skilled in advanced molecular techniques, including RNA/DNA extraction, flow cytometry, microbiological assays, and animal model studies. With a strong background in mentoring Master’s and Ph.D. students, she has contributed significantly to multiple high-impact publications. Passionate about advancing knowledge in immune-mediated diseases, Shaghayegh’s work has led to groundbreaking approaches in diagnostics and therapeutic development.

Profile

Education

Shaghayegh Baradaran Ghavami holds a Ph.D. in Microbiology from Azad University, Science and Research Branch, Tehran, Iran (2010-2015). Prior to that, she completed her M.Sc. in Microbiology at Islamic Azad University, North Tehran Branch, Iran (2008-2010). Her extensive academic background laid the foundation for her research in immunology and microbiology, specifically focusing on autoimmune diseases. Throughout her education, Shaghayegh demonstrated a commitment to deepening scientific understanding, leading her to pursue a career in both laboratory and clinical research, where she has made significant contributions to advancing medical practices and patient outcomes.

Experience

Shaghayegh Baradaran Ghavami has over a decade of experience in both clinical and academic research. She is currently a Postdoctoral Fellow at the Research Institute for Gastroenterology and Liver Disease at Shaheed Beheshti University of Medical Sciences (2018-2026), where she oversees research design, data analysis, and project dissemination. Previously, she served as a Clinical Research Fellow at the same institution (2016-2018), where she coordinated research teams and contributed to numerous publications. Additionally, she worked as a tutor at Azad University, Tehran, supporting students through complex microbiological concepts and promoting critical thinking. Her professional experience spans across experimental research, research proposal development, grant management, and academic mentoring.

Awards and Honors

Shaghayegh Baradaran Ghavami has received several prestigious recognitions in her research career. In 2020, she was awarded a $30,000 research grant from Orchid Life Company for her project on IBD and COVID-19. Her work has also earned her opportunities to present at major international conferences, such as the “Advanced Immunology 2023” congress in London and the “Microbiota MI 2020” meeting in Milan. Her research achievements are consistently acknowledged through citations in high-impact journals, showcasing her contributions to the fields of immunology and microbiology. Shaghayegh’s awards and honors reflect her dedication to advancing scientific knowledge and therapeutic innovations in autoimmune diseases.

Research Focus

Shaghayegh Baradaran Ghavami’s research is focused on advancing the understanding of immune-mediated diseases, particularly Inflammatory Bowel Disease (IBD). Her work explores the immunomodulatory effects of probiotics, the role of the gut microbiota, and the use of nanocomposite-based therapies to manage autoimmune diseases. She investigates the mechanisms underlying the interaction between viral infections and immune responses in IBD patients, providing insights into new therapeutic approaches. Shaghayegh’s research aims to develop novel diagnostic tools and interventions that can improve the quality of life for individuals suffering from autoimmune conditions. Her studies have contributed to enhancing the understanding of dendritic cells, immunological markers, and their potential as therapeutic targets for IBD.

Publication Top Notes

  • “Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases” 📚🦠
  • “Evaluation of tumor necrosis factor (TNF)-α mRNA expression level and the rs1799964 polymorphism of the TNF-α gene in peripheral mononuclear cells of patients with inflammatory…” 🔬🧬
  • “The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: a modeling study” 🌏📊
  • “Mesenchymal stem cell spheroids embedded in an injectable thermosensitive hydrogel: an in situ drug formation platform for accelerated wound healing” 🧫💉
  • “Immunomodulation and generation of tolerogenic dendritic cells by probiotic bacteria in patients with inflammatory bowel disease” 🦠🧘‍♀️
  • “Cross-talk between immune system and microbiota in COVID-19” 🦠🌍
  • “Overview of three proliferation pathways (Wnt, Notch, and Hippo) in intestine and immune system and their role in inflammatory bowel diseases (IBDs)” 🔬🧬
  • “Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy” 💊🦠
  • “Probiotic-induced tolerogenic dendritic cells: a novel therapy for inflammatory bowel disease?” 💉🔬
  • “Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice” 🤔💊
  • “The critical role of gut-brain axis microbiome in mental disorders” 🧠🌱